Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis

Scandinavian Journal of Immunology

Volumn 58, Issue 1, 2003, Pages 81-88

  Glabinski, A R ^a   Bielecki, B ^a   Ransohoff, R M ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE; GENE EXPRESSION REGULATION; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION GENE 3; UPREGULATION;

ANIMALS; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; SPINAL CORD; SPLEEN; UP-REGULATION;

EID: 0038346600     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01285.x     Document Type: Article

References (33)

1. Glabinski AR, Ransohoff RM. Sentries at the gate: chemokines and the blood-brain barrier. J Neurovirol 1999;5:623-34.
2. Bacon KB, Harrison JK. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J Neuroimmunol 2000; 104:92-7.
3. Karpus WJ. Chemokines and central nervous system disorders. J Neurovirol 2001;7:493-500.
4. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
5. Luster F. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
6. Hulkower K, Brosnan CF, Aquino DA et al. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol 1993;150:2525-33.
7. Ransohoff RM, Hamilton TA, Tani M et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 1993;7:592-602.
8. Godiska R, Chantry D, Dietsch G, Gray P. Chemokine expression in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;58:167-76.
9. Glabinski A, Tani M, Strieter R, Tuohy V, Ransohoff R. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 1997;150:617-30.
10. Glabinski A, Tani M, Tuohy V, Tuthill R, Ransohoff RM. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 1995;9:315-30.
11. McManus C, Brosnan C, Berman J. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J Immunol 1998;160:1449-55.
12. Zhou Z-HL, Chaturvedi P, Han Y et al. IFN-gamma induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: functional interaction between an IFN-gamma-activated site and a GC-rich element. J Immunol 1998;160:3908-16.
13. Zach O, Bauer HC, Richter K, Webersinke G, Tontsch S, Bauer H. Expression of a chemotactic cytokine (MCP_1) in cerebral capillary endothelial cells in vitro. Endothelium 1997;5:143-53.
14. Yu M, Nishiyama A, Trapp B, Tuohy V. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 1996;64:91-100.
15. Glabinski A, Tuohy V, Ransohoff R. Expression of chemokines RANTES, MIP-1 alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuro-immunomodulation 1998;5:166-71.
16. Nygardas PT, Maatta JA, Hinkkanen AE. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse. Eur J Immunol 2000;30:1911-8.
17. Rajan AJ, Asensio VC, Campbell IL, Brosnan CF. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J Immunol 2000;164:2120-30.
18. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental auotimmune encephalomyelitis. J Immunol 1995;155:5003-10.
19. Kennedy K, Strieter R, Kunkel S, Lukacs N, Karpus W. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1 and monocyte chemotactic protein1. J Neuroimmunol 1998;92:98-108.
20. Matsui M, Weaver J, Proudfoot AEI et al. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J Neuroimmunol 2002;128:16-22.
21. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999;20:307-12.
22. Hurwitz AA, Lyman WD, Berman JW. Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J Neuroimmunol 1995;57:193-8.
23. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J Neuroimmunol 1995;60:143-50.
24. Ehrlich L, Hu S, Sheng W et al. Cytokine regulation of human microglial cell IL-8 production. J Immunol 1998;160:1944-8.
25. Glabinski A, Krakowski M, Han Y, Owens T, Ransohoff R. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis. J Neurovirol 1999;5:95-101.
26. Tran EH, Prince EN, Owens T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol 2000;164:2759-68.
27. Hamilton N, Banyer J, Hapel A et al. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis. Scand J Immunol 2002;55:171-7.
28. Matejuk A, Dwyer J, Ito A, Bruender Z, Vandenbark A, Offner H. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE. J Neurosci Res 2002;67:680-8.
29. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A 1991;88:2918-21.
30. Racke MK, Canella B, Albert P, Sporn M, Raine CS, McFarlin DE. Evidence of endogenous regulatory function of transforming growth factor beta 1 in experimental allergic encephalomyelitis. Int Immunol 1992;4:615-20.
31. Chen Y, Inobe J, Weiner HL. Induction of oral tolerance to myelin basic protein in CD8-depleted mice. both CD4+ and CD8+ cells mediate active suppression. J Immunol 1995;155:910-6.
32. Sun J-B, Xiao B-G, Lindblad M et al. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. Int Immunol 2000;12:1449-57.
33. Yu M, Johnson J, Tuohy V. A predictable sequential pattern of determinant spreading invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-88.